[1]
Girish Vasudeorao Kumthekar and Rajasekara Chakravarthi Madarasu, “Utility of Testing Fibroblast Growth Factor 23 in Patients with Chronic Kidney Disease: A Single Center Experience”, IDMMR-V7, pp. 119–127, Feb. 2022.